Supply API Powder CAS 540737 -29-9 Tofacitinib Citrate

China Supply API Powder CAS 540737-29-9 Tofacitinib Citrate, Find details about China Tofacitinib Citrate, 540737-29-9 from Supply API Powder CAS 540737-29-9 Tofacitinib Citrate

Basic Info.

Model NO.

TY-02AL

CAS

540737-29-9

Appearance

White Liquid

Einecs

616-396-9

Assay

99%

Shelf

2 Years

Trademark

tongyon

Transport Package

25kg/Drum 5g, 100g, 500g, 1kg, 10kg, 100kg, 200kg

Specification

25kg/drum

Origin

China

Model NO.

TY-02AL

CAS

540737-29-9

Appearance

White Liquid

Einecs

616-396-9

Assay

99%

Shelf

2 Years

Trademark

tongyon

Transport Package

25kg/Drum 5g, 100g, 500g, 1kg, 10kg, 100kg, 200kg

Specification

25kg/drum

Origin

China

Product Desciption

Product name	Tofacitinib Citrate
CAS	540737-29-9
Appearance	white powder
Assay	99%
Storage	Cool and Protect from light

Product Name:Tofacitinib Citrate
CAS:540737-29-9
MF:C16H20N6O.C6H8O7
MW:504.497
EINECS:638-826-4
Properties
Melting point:201 °C (decomp)
storage temp. room temp
solubility DMSO: soluble5mg/mL (clear solution; warmed)
form powder
color white to beige
InChIKeySYIKUFDOYJFGBQ-YLAFAASESA-N

Supply API Powder CAS 540737-29-9 Tofacitinib Citrate

Description
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.[2][3] Seven clinical trials evaluated the safety and efficacy of Tofacitinib citrate in moderate to severe active RA in adult patients.In all tests, compared with patients receiving placebo, patients receiving Tofacitinib Citrate treatment showed significant improvement in clinical response and physical function.
In Clinical trials, the most common adverse events were upper respiratory tract infection, headache, diarrhea, nasal congestion,sore throat, and nasopharyngitis.
Using Tofacitinib Citrate was associated with an increased risk of serious infections, including opportunistic infections, tuberculosis,
cancer and lymphoma. Tofacitinib Citrate product label attaches boxed warning on these security risks. Tofacitinib Citrate treatment is also associated with reducing blood cell counts and increasing cholesterol and liver enzyme values.

GuangZhou TongYi biochemistry technology Co., Ltd is a company specializing in active pharmaceutical ingredient
(API), biology, plant extracts, chemical raw materials, fine chemicals, pharmaceutical intermediates, cosmetics raw
material. Our company has always adhered to the company philosophy of integrity, professionalism, quality first, and
customer service. With the efforts of all the company's employees, it has established long-term
and stable cooperative relations with many domestic and foreign customers, and won the unanimous trust of domestic
and foreign customers. With good comments, our company have made great progress.

Our company takes pioneering and innovative, high-quality and efficient as the code of conduct, and strives to provide
customers with efficient services,
high-quality products, and reasonable prices. We have established a customer demand-oriented, flexible, diverse and customizable service according to the different needs of different customers. Mode, and ultimately achieve the goal of
win-win.

Our company focuses on the future and the world, and will continue to devote itself to technological progress and the
development of new products in the future, hoping to work hand in hand with new and old friends at home and abroad
to create a better future.

Supply API Powder CAS 540737-29-9 Tofacitinib Citrate